JP2019518437A5 - - Google Patents

Download PDF

Info

Publication number
JP2019518437A5
JP2019518437A5 JP2018556974A JP2018556974A JP2019518437A5 JP 2019518437 A5 JP2019518437 A5 JP 2019518437A5 JP 2018556974 A JP2018556974 A JP 2018556974A JP 2018556974 A JP2018556974 A JP 2018556974A JP 2019518437 A5 JP2019518437 A5 JP 2019518437A5
Authority
JP
Japan
Prior art keywords
cancer
snv
specific
amount
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018556974A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019518437A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/030291 external-priority patent/WO2017190104A1/en
Publication of JP2019518437A publication Critical patent/JP2019518437A/ja
Publication of JP2019518437A5 publication Critical patent/JP2019518437A5/ja
Priority to JP2022029376A priority Critical patent/JP2022084647A/ja
Pending legal-status Critical Current

Links

JP2018556974A 2016-04-29 2017-04-29 多重/最適化ミスマッチ増幅(moma)−がんの評価のためのリアルタイムpcr Pending JP2019518437A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022029376A JP2022084647A (ja) 2016-04-29 2022-02-28 多重/最適化ミスマッチ増幅(moma)-がんの評価のためのリアルタイムpcr

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662330043P 2016-04-29 2016-04-29
US62/330,043 2016-04-29
PCT/US2017/030291 WO2017190104A1 (en) 2016-04-29 2017-04-29 Multiplexed optimized mismatch amplification (moma)-real time pcr for assessing cancer

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022029376A Division JP2022084647A (ja) 2016-04-29 2022-02-28 多重/最適化ミスマッチ増幅(moma)-がんの評価のためのリアルタイムpcr

Publications (2)

Publication Number Publication Date
JP2019518437A JP2019518437A (ja) 2019-07-04
JP2019518437A5 true JP2019518437A5 (https=) 2020-06-18

Family

ID=58709564

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018556974A Pending JP2019518437A (ja) 2016-04-29 2017-04-29 多重/最適化ミスマッチ増幅(moma)−がんの評価のためのリアルタイムpcr
JP2022029376A Pending JP2022084647A (ja) 2016-04-29 2022-02-28 多重/最適化ミスマッチ増幅(moma)-がんの評価のためのリアルタイムpcr

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022029376A Pending JP2022084647A (ja) 2016-04-29 2022-02-28 多重/最適化ミスマッチ増幅(moma)-がんの評価のためのリアルタイムpcr

Country Status (11)

Country Link
US (1) US20200181681A1 (https=)
EP (1) EP3449014A1 (https=)
JP (2) JP2019518437A (https=)
CN (1) CN109715826A (https=)
AU (1) AU2017258799A1 (https=)
BR (1) BR112018072195A2 (https=)
CA (1) CA3022545A1 (https=)
EA (1) EA201892491A1 (https=)
IL (1) IL262640A (https=)
MX (1) MX2018013223A (https=)
WO (1) WO2017190104A1 (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11111543B2 (en) 2005-07-29 2021-09-07 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US9424392B2 (en) 2005-11-26 2016-08-23 Natera, Inc. System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals
US12152275B2 (en) 2010-05-18 2024-11-26 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US9677118B2 (en) 2014-04-21 2017-06-13 Natera, Inc. Methods for simultaneous amplification of target loci
US11939634B2 (en) 2010-05-18 2024-03-26 Natera, Inc. Methods for simultaneous amplification of target loci
US10316362B2 (en) 2010-05-18 2019-06-11 Natera, Inc. Methods for simultaneous amplification of target loci
US20190010543A1 (en) 2010-05-18 2019-01-10 Natera, Inc. Methods for simultaneous amplification of target loci
US12221653B2 (en) 2010-05-18 2025-02-11 Natera, Inc. Methods for simultaneous amplification of target loci
US11322224B2 (en) 2010-05-18 2022-05-03 Natera, Inc. Methods for non-invasive prenatal ploidy calling
AU2011358564B9 (en) 2011-02-09 2017-07-13 Natera, Inc Methods for non-invasive prenatal ploidy calling
US20140100126A1 (en) 2012-08-17 2014-04-10 Natera, Inc. Method for Non-Invasive Prenatal Testing Using Parental Mosaicism Data
US20180173845A1 (en) 2014-06-05 2018-06-21 Natera, Inc. Systems and Methods for Detection of Aneuploidy
WO2016183106A1 (en) 2015-05-11 2016-11-17 Natera, Inc. Methods and compositions for determining ploidy
WO2017181202A2 (en) 2016-04-15 2017-10-19 Natera, Inc. Methods for lung cancer detection
GB201618485D0 (en) 2016-11-02 2016-12-14 Ucl Business Plc Method of detecting tumour recurrence
CA3042722A1 (en) * 2016-11-02 2018-05-11 The Medical College Of Wisconsin, Inc. Methods for assessing risk using mismatch amplification and statistical methods
AU2018288832B2 (en) 2017-06-20 2025-03-06 The Medical College Of Wisconsin, Inc. Assessing transplant complication risk with total cell-free DNA
JP2021506342A (ja) 2017-12-14 2021-02-22 ティーエーアイ ダイアグノスティックス インコーポレイテッドTai Diagnostics,Inc. 移植のための移植片適合性の評価
CA3090426A1 (en) 2018-04-14 2019-10-17 Natera, Inc. Methods for cancer detection and monitoring by means of personalized detection of circulating tumor dna
US12234509B2 (en) 2018-07-03 2025-02-25 Natera, Inc. Methods for detection of donor-derived cell-free DNA
US11931674B2 (en) 2019-04-04 2024-03-19 Natera, Inc. Materials and methods for processing blood samples

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6034065A (en) 1992-12-03 2000-03-07 Arizona Board Of Regents Elucidation and synthesis of antineoplastic tetrapeptide phenethylamides of dolastatin 10
DE69832158T2 (de) 1997-02-25 2006-08-10 Arizona Board Of Regents, Tempe Isolierung und strukturelle aufklärung der kryostatischen linearen und cyclo-depsipeptide dolastatin 16, dolastatin 17, und dolastatin 18
US20030148301A1 (en) * 1999-12-10 2003-08-07 Toshiya Aono Method of detecting nucleotide polymorphism
JP4116856B2 (ja) * 2002-10-02 2008-07-09 富士フイルム株式会社 1塩基多型の検出方法
CN102892901B (zh) * 2010-03-24 2015-11-25 凸版印刷株式会社 利用竞争性引物的目标碱基序列的检测方法
US10077474B2 (en) * 2012-05-29 2018-09-18 Abbott Molecular, Inc. Method of designing primers, method of detecting single nucleotide polymorphisms (SNPs), method of distinguishing SNPs, and related primers, detectable oligonucleotides, and kits
US20140242582A1 (en) 2013-02-28 2014-08-28 Ariosa Diagnostics, Inc. Detection of genetic abnormalities using ligation-based detection and digital pcr
CN115029342B (zh) * 2014-08-22 2025-04-08 分析生物科学有限公司 用于无细胞dna的定量遗传分析的方法
US20180142296A1 (en) * 2015-04-30 2018-05-24 Medical College Of Wisconsin, Inc. Multiplexed optimized mismatch amplification (moma)-real time pcr for assessing cell-free dna

Similar Documents

Publication Publication Date Title
JP2019518437A5 (https=)
JP2019514387A5 (https=)
JP2022180384A5 (https=)
US11633732B2 (en) CRISPR effector system based diagnostics
Sihto et al. Clinical factors associated with Merkel cell polyomavirus infection in Merkel cell carcinoma
JP2018514219A5 (https=)
JP2022002508A (ja) 無細胞dnaを評価するための多重/最適化ミスマッチ増幅(moma)−リアルタイムpcr
Macher et al. Monitoring of transplanted liver health by quantification of organ-specific genomic marker in circulating DNA from receptor
JP2014073134A5 (ja) 標的増幅及びシークエンシングを使用した非侵襲的な胎児遺伝子型スクリーニング
EP2426217A1 (en) Analytical methods for cell free nucleic acids and applications
JP6140422B2 (ja) 反復dnaエレメント(line/sine)を陰性対照として用いる、次世代シークエンシングのための標的濃縮の効率を予測するための、定量pcrに基づく方法
Szpechcinski et al. Plasma cell-free DNA levels and integrity in patients with chest radiological findings: NSCLC versus benign lung nodules
JP2019534017A5 (https=)
Jackson et al. Multiplex preamplification of serum DNA to facilitate reliable detection of extremely rare cancer mutations in circulating DNA by digital PCR
Cabanero et al. Circulating tumour DNA in EGFR-mutant non-small-cell lung cancer
CN106795563B (zh) 用于快速并且灵敏地检测热点突变的方法
JP6636247B2 (ja) WT1mRNAの発現量定量方法
US20250346949A1 (en) Methods and kits for determining the efficiency of plasma separation from whole blood
Moskalev et al. Increased detection rates of EGFR and KRAS mutations in NSCLC specimens with low tumour cell content by 454 deep sequencing
CN105283559A (zh) 短端粒丰度的量度
Bartley et al. A DNA real-time quantitative PCR method suitable for routine monitoring of low levels of minimal residual disease in chronic myeloid leukemia
Keller et al. miRNAs in ancient tissue specimens of the Tyrolean Iceman
JP6054750B2 (ja) 肝細胞癌のリスク評価方法
CN107988427A (zh) 对虾肝胰腺细小病毒(hpv)的raa恒温荧光检测方法及试剂
Hara et al. Relationship between DNA degradation ratios and the number of loci detectable by STR kits in extremely old seminal stain samples